Modafinil

Glossary / Nootropics / Modafinil
NOOTROPICS · GLOSSARY ENTRY

Modafinil

A wakefulness-promoting prescription medication — FDA-approved for narcolepsy and shift-work sleep disorder, widely used off-label as a cognitive enhancer.

Why it matters

Modafinil acts primarily as a dopamine reuptake inhibitor with additional effects on histamine, orexin, and norepinephrine systems. It produces sustained wakefulness and improved sustained attention without the same dependency profile or peripheral stimulant effects as amphetamines.

In practice

Off-label use for cognitive enhancement is common despite legal restrictions. Typical doses are 100–200mg in the morning. Side effects include headache, GI upset, and rare but serious dermatological reactions (Stevens-Johnson syndrome).

Common confusion

“Modafinil has no abuse potential” is wrong — the abuse potential is lower than classical stimulants but real.

RELATED TERMS
SOURCES

    This glossary entry is editorial content reviewed against primary sources. It is not medical advice. See our Editorial Policy.

    Scroll to Top

    Disclaimer: Alternative Pharm Press is an independent editorial publication and brand directory; we do not sell, manufacture, or ship any products. The statements and products referenced on this site have not been evaluated by the U.S. Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease. Content is provided for general informational and educational purposes only and is not medical, legal, or professional advice. Always consult a licensed healthcare provider before using kratom, cannabis, CBD, hemp, nootropic, peptide, or any related product, especially if you are under 21, pregnant or nursing, taking medication, or managing a health condition. The legal status of these products varies by country, state, and locality; you are solely responsible for verifying and complying with the laws that apply to you. Some listings, reviews, and coupons may be paid placements or affiliate relationships, which do not influence our editorial standards.